Charles Schwab’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.1M Buy
453,429
+36,386
+9% +$2.1M ﹤0.01% 1521
2025
Q1
$24.3M Sell
417,043
-9,391
-2% -$547K ﹤0.01% 1527
2024
Q4
$34.3M Buy
426,434
+23,869
+6% +$1.92M 0.01% 1384
2024
Q3
$32.3M Buy
402,565
+46,665
+13% +$3.74M 0.01% 1413
2024
Q2
$21.7M Buy
355,900
+14,609
+4% +$892K ﹤0.01% 1625
2024
Q1
$16.9M Buy
341,291
+6,174
+2% +$305K ﹤0.01% 1710
2023
Q4
$14M Buy
335,117
+13,868
+4% +$581K ﹤0.01% 1813
2023
Q3
$10.5M Buy
321,249
+69,525
+28% +$2.28M ﹤0.01% 1880
2023
Q2
$8.9M Buy
251,724
+25,556
+11% +$903K ﹤0.01% 1956
2023
Q1
$6.42M Sell
226,168
-914
-0.4% -$26K ﹤0.01% 2089
2022
Q4
$9.43M Buy
227,082
+5,892
+3% +$245K ﹤0.01% 1891
2022
Q3
$9.17M Buy
221,190
+130,141
+143% +$5.4M ﹤0.01% 1888
2022
Q2
$2.98M Buy
91,049
+39,658
+77% +$1.3M ﹤0.01% 2417
2022
Q1
$1.8M Buy
51,391
+1,206
+2% +$42.2K ﹤0.01% 2682
2021
Q4
$1.26M Buy
+50,185
New +$1.26M ﹤0.01% 2826